NSE › Healthcare

IPCA Laboratories Limited (IPCALAB)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,725.60-1.27%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹2,388 cr
Revenue YoY
+6.2%
Net profit
₹299 cr
Profit YoY
+341.0%
EPS
₹13.31
EPS estimate
₹10.45
Net margin
12.5%

EPS came in at 13.31 against a street estimate of 10.45 — a beat of 27.4%.

Key statistics

Market cap
₹44,195 cr
P/E
38.8
Forward P/E
26.5
P/B
5.50
Book value
₹317.84
EPS (TTM)
₹44.92
Dividend yield
0.34%
52-week high
₹1,944.90
52-week low
₹1,251.60
50-day MA
₹1,683.81
200-day MA
₹1,522.19
Beta
0.05

Analyst view

with an average price target of ₹1,733.50.

Shareholding

Promoters
45.08%
Institutions
45.16%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for IPCA Laboratories Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.